Skip to content

Calcium Phosphate Versus PMMA Cement in Thoracolumbar Fractures

Calcium Phosphate Versus PMMA Cement in Unstable Thoracolumbar Burst Fractures Treated With Dorsal Instrumentation in Patients > 50 Years of Age Randomized Controlled Non-inferiority Trial Design

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04743869
Acronym
CaPvsPMMA
Enrollment
85
Registered
2021-02-08
Start date
2021-02-28
Completion date
2024-02-29
Last updated
2021-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

SPINAL Fracture

Keywords

Spinal Fractures, Fractures, Polymethyl Methacrylate, PMMA, Bone Cements, Calciumphosphate, Thoracolumbar Fractures, Dorsal Instrumentation, Burst Fractures, Balloon Kyphoplasty

Brief summary

Patients at the age of 50 or older presenting with thoracolumbar fractures including segments TH 6-L5 and A3/A4 fractures according to the AO Spine fracture classification after the acute trauma and planned surgery within 3 weeks following trauma will be asked to participate in a randomized trial in which they will receive either Calciumphosphate (CaP) or Polymethylmethacrylate (PMMA) as part of a standardized treatment approach. Regardless of the group patients are randomized to, all participating patients undergo the same surgical procedure except for the preparation and administration of bone cement. The study participation period for each patient is 1 year from the date of the surgery and includes 4 defined time points that include follow-up clinical visits for imaging and progress checks at 6 weeks, 3 months, 6 months and 12 months after surgery. At each follow-up visit, a combination of questionnaires and radiological imaging will be performed to assess general health status, disability level and pain control, as well as objective results of the surgery. The main outcome measure will be the loss of correction rate that will be measured through the bi-segmental COBB angle presented in the CT-scan.

Interventions

DEVICEKyphos FS™ Bone Substitute

Dorsal instrumentation via Longitude II (Medtronic Austria GmbH/Vienna) and balloon kyphoplasty are performed. KyphOs FS™ bone cement will be introduced in the fractured vertebral body.

DEVICEKYPHON ActivOs® Bone Cement with Hydroxyapatite

Dorsal instrumentation via Longitude II (Medtronic Austria GmbH/Vienna) and balloon kyphoplasty are performed. KYPHON ActivOs® Bone Cement with Hydroxyapatite will be introduced in the fractured vertebral body.

Sponsors

Medical University of Graz
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Masking description

Patients and study nurse will be blinded to treatment allocation; however, surgeons cannot be blinded due to different techniques of bone cement application. A centralized and automated internet-based randomization system will ensure concealed randomization of study participants. Participants will be the unit of randomization. Randomization will be carried out with randomizer.at and will occur prior to the surgical procedure.

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Written consent of the participant after being informed * Acute trauma (surgery within three weeks following trauma) * Thoracolumbar fractures including segments TH 6-L5 * A3/A4 fractures according to the AO Spine fracture classification * Patient age ≥ 50 years * Minimum follow up 1 year

Exclusion criteria

* Presence of neurological deficits at the time of surgery * Pathological fractures (bone metastases) * Traumatic brain injury * Ankylosing spondylitis as a comorbidity * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
The change in correction rates when using CaPPreoperatively (determination of fracture classification), postoperatively (immediately following surgery), 1 year postoperativelyThe main outcome measure 1 will be the loss of correction rate that will be measured through the bi-segmental COBB angle presented in the CT-scan. The Cobb angle will be measured between the superior end plate of the vertebral body cephalad to the injury and the inferior end plate of the vertebral body caudal to the injury.
The change in correction rates when using PMMAPreoperatively (determination of fracture classification), postoperatively (immediately following surgery), 1 year postoperativelyThe main outcome 2 measure will be the loss of correction rate that will be measured through the bi-segmental COBB angle presented in the CT-scan. The Cobb angle will be measured between the superior end plate of the vertebral body cephalad to the injury and the inferior end plate of the vertebral body caudal to the injury. Measurements will be taken from CT scans.

Secondary

MeasureTime frameDescription
Changes in complication rates when using PMMA6 weeks, 3 months, 6 months and 12 months postoperativelyThe occurence of the complication rates, in particular cement extravasation and temporary fall in blood pressure, will be compared between the two groups for each time point using the Student´s t-test for independent samples. In addition, a paired Student´s t-test will be performed within each group in order to evaluate the differences in means of the secondary endpoints measured at the defined timepoints.
Changes in complication rates when using CaP6 weeks, 3 months, 6 months and 12 months postoperativelyThe occurence of the complication rates, in particular cement extravasation and temporary fall in blood pressure, will be compared between the two groups for each time point using the Student´s t-test for independent samples. In addition, a paired Student´s t-test will be performed within each group in order to evaluate the differences in means of the secondary endpoints measured at the defined timepoints.
Change in the disability on the ODI rating scale in patients with PMMAFive times - after the surgery, at each study visit (6 weeks, 3 months, 6 months and 12 months postoperatively)ODI is mainly used in spine trauma patients. A score of 0% to 20% indicates minimal disability; 21% to 40%, moderate disability; and 41% to 60% severe disability.
Change in the disability on the ODI rating scale in patients with CaPFive times - after the surgery, at each study visit (6 weeks, 3 months, 6 months and 12 months postoperatively)ODI is mainly used in spine trauma patients. A score of 0% to 20% indicates minimal disability; 21% to 40%, moderate disability; and 41% to 60% severe disability.
The change in vertebral body height when using CaPPreoperatively, postoperatively (immediately following the surgery), 1 year postoperativelyThe percentage loss of the vertebral body height will be calculated by dividing the height of the fractured vertebra by the average height of the cephalad and caudad vertebrae and then subtracting this number from 100%. Measurements will be taken from CT scans.
Change in pain on the spine VAS in patients with CaPFive times - after the surgery, at each study visit (6 weeks, 3 months, 6 months and 12 months postoperatively)VAS - Spine Visual Analogue Scale is a measurement that measures pain intensity and it is completed by patients themselves.
Change in quality of life in patients with PMMA measured by the 36-item Short Form SurveyFive times - after the surgery, at each study visit (6 weeks, 3 months, 6 months and 12 months postoperatively)The 36-Item Short Form Survey (SF-36) will be used to assess patient´s self-reported quality of life.
Change in quality of life in patients with CaP measured by the 36-item Short Form SurveyFive times - after the surgery, at each study visit (6 weeks, 3 months, 6 months and 12 months postoperatively)The 36-Item Short Form Survey (SF-36) will be used to assess patient´s self-reported quality of life.
Change in pain on the spine VAS in patients with PMMAFive times - after the surgery, at each study visit (6 weeks, 3 months, 6 months and 12 months postoperatively)VAS - Spine Visual Analogue Scale is a measurement that measures pain intensity and it is completed by patients themselves.
The change in vertebral body height when using PMMAPreoperatively, postoperatively (immediately following the surgery), 1 year postoperativelyThe percentage loss of the vertebral body height will be calculated by dividing the height of the fractured vertebra by the average height of the cephalad and caudad vertebrae and then subtracting this number from 100%.

Contacts

Primary ContactGloria Hohenberger, Assist.Prof.
gloria.hohenberger@medunigraz.at+43 316 385 81721
Backup ContactMarina Bergovec, Dr. Sc.
marina.bergovec@medunigraz.at+43 316 385 87436

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026